Legal Representation
Attorney
NIGAMNARAYAN ACHARYA
USPTO Deadlines
Next Deadline
138 days remaining
NOA E-Mailed - SOU Required
Due Date
December 03, 2025
Extension Available
Until June 03, 2026
Application History
30 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jun 3, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Apr 8, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Apr 8, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Apr 2, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Mar 13, 2025 | EXPT | T | EXPARTE APPEAL TERMINATED | Loading... |
Mar 13, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Feb 11, 2025 | EXPI | T | EX PARTE APPEAL-INSTITUTED | Loading... |
Feb 11, 2025 | JURT | T | JURISDICTION RESTORED TO EXAMINING ATTORNEY | Loading... |
Feb 6, 2025 | PGTT | O | PETITION GRANTED - TTAB APPEAL FILED | Loading... |
Feb 6, 2025 | NREV | E | NOTICE OF REVIVAL - E-MAILED | Loading... |
Feb 4, 2025 | APET | A | ASSIGNED TO PETITION STAFF | Loading... |
Jan 18, 2025 | EXAF | T | EXPARTE APPEAL RECEIVED AT TTAB | Loading... |
Dec 17, 2024 | EXAF | T | EXPARTE APPEAL RECEIVED AT TTAB | Loading... |
Dec 17, 2024 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | Loading... |
Oct 17, 2024 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
Oct 17, 2024 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
Jul 3, 2024 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
Jul 3, 2024 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
Jul 3, 2024 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
May 14, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
May 14, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
May 14, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Feb 14, 2024 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
Feb 14, 2024 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
Nov 14, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Nov 14, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Nov 14, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Nov 9, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Mar 2, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Feb 15, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Pharmaceutical research and development services in the field of oncology, namely, neuro and central nervous system oncology; pharmaceutical drug discovery services in the field of oncology; scientific and medical research and development for pharmaceuticals, pharmaceutical preparations and substances in the field of oncology, namely, neuro and central nervous system oncology
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
THERAPEUTICS